(Q34808094)

4 August 2017

1 reference

title

Strategies for improving quality of life in older patients with metastatic breast cancer (English)

1 reference

4 August 2017

1 reference

Jean-Emmanuel Kurtz

1

1 reference

4 August 2017

Patrick Dufour

series ordinal

2

1 reference

4 August 2017

publication date

1 January 2002

1 reference

4 August 2017

1 reference

4 August 2017

volume

19

1 reference

4 August 2017

issue

8

1 reference

4 August 2017

page(s)

605-622

1 reference

https://scigraph.springernature.com/pub.10.2165/00002512-200219080-00006

4 August 2017

exact match

0 references

cites work

Anastrozole versus tamoxifen as first-line therapy for advanced breast cancer in 668 postmenopausal women: results of the Tamoxifen or Arimidex Randomized Group Efficacy and Tolerability study

1 reference

12 December 2020

Exemestane is superior to megestrol acetate after tamoxifen failure in postmenopausal women with advanced breast cancer: results of a phase III randomized double-blind trial. The Exemestane Study Group.

1 reference

12 December 2020

Idarubicin and cyclophosphamide--an active oral chemotherapy regimen for advanced breast cancer

1 reference

12 December 2020

Formestane is feasible and effective in elderly breast cancer patients with comorbidity and disability

1 reference

12 December 2020

Cancer chemotherapy in older adults. A tolerability perspective

1 reference

12 December 2020

Health values of the seriously ill. SUPPORT investigators

1 reference

12 December 2020

Phase III, multicenter, double-blind, randomized study of letrozole, an aromatase inhibitor, for advanced breast cancer versus megestrol acetate

1 reference

12 December 2020

Patterns of use of chemotherapy for breast cancer in older women: findings from Medicare claims data

1 reference

12 December 2020

Effects of demographic variables on vorozole pharmacokinetics in healthy volunteers and in breast cancer patients.

1 reference

12 December 2020

High activity and tolerability demonstrated for exemestane in postmenopausal women with metastatic breast cancer who had previously failed on tamoxifen treatment.

1 reference

12 December 2020

Advanced breast cancer: a phase II trial with gemcitabine

1 reference

12 December 2020

American Society of Clinical Oncology guideline on the role of bisphosphonates in breast cancer. American Society of Clinical Oncology Bisphosphonates Expert Panel

1 reference

12 December 2020

Oral idarubicin and cyclophosphamide for metastatic breast cancer in elderly patients

1 reference

12 December 2020

Patient preferences for oral versus intravenous palliative chemotherapy

1 reference

12 December 2020

Fluorouracil and the new oral fluorinated pyrimidines

1 reference

12 December 2020

The effect of comorbidity on 3-year survival of women with primary breast cancer

1 reference

12 December 2020

Patient perceptions of the side-effects of chemotherapy: the influence of 5HT3 antagonists

1 reference

12 December 2020

Reliability and validity of the Functional Assessment of Cancer Therapy-Breast quality-of-life instrument.

1 reference

12 December 2020

Treatment of advanced breast cancer with sterically stabilized liposomal doxorubicin: results of a multicenter phase II trial

1 reference

12 December 2020

Formestane. A review of its pharmacological properties and clinical efficacy in the treatment of postmenopausal breast cancer

1 reference

12 December 2020

Identification and interpretation of clinical and quality of life prognostic factors for survival and response to treatment in first-line chemotherapy in advanced breast cancer.

1 reference

12 December 2020

Phase II study of oral idarubicin in elderly patients with advanced breast cancer.

1 reference

12 December 2020

Palliative effect of chemotherapy: objective tumor response is associated with symptom improvement in patients with metastatic breast cancer

1 reference

12 December 2020

A prospective pharmacologic evaluation of age-related toxicity of adjuvant chemotherapy in women with breast cancer.

1 reference

12 December 2020

Burdens and benefits of adjuvant cyclophosphamide, methotrexate, and fluorouracil and tamoxifen for elderly patients with breast cancer: the International Breast Cancer Study Group Trial VII.

1 reference

12 December 2020

Breast cancer and aging. Clinical interactions

1 reference

12 December 2020

Cognitive deficits after postoperative adjuvant chemotherapy for breast carcinoma.

1 reference

12 December 2020

Superior efficacy of letrozole versus tamoxifen as first-line therapy for postmenopausal women with advanced breast cancer: results of a phase III study of the International Letrozole Breast Cancer Group

1 reference

12 December 2020

Formestane versus megestrol acetate in postmenopausal breast cancer patients after failure of tamoxifen: a phase III prospective randomised cross over trial of second-line hormonal treatment (SAKK 20/90). Swiss Group for Clinical Cancer Research (SA

1 reference

12 December 2020

Vinorelbine as first-line chemotherapy for advanced breast cancer in women 60 years of age or older

1 reference

12 December 2020

Assessment of the older cancer patient

1 reference

12 December 2020

Cyclophosphamide, methotrexate, and 5-fluorouracil chemotherapy in women more than 65 years old with advanced breast cancer: the elimination of age trends in toxicity by using doses based on creatinine clearance

1 reference

12 December 2020

Are older French patients as willing as older American patients to undertake chemotherapy?

1 reference

12 December 2020

Correlation of toxicity with pharmacokinetics of pegylated liposomal doxorubicin (Doxil) in metastatic breast carcinoma

1 reference

12 December 2020

The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology

1 reference

12 December 2020

Potential role of oral anthracyclines in older patients with cancer

1 reference

12 December 2020

Effect of megestrol acetate on quality of life in a dose-response trial in women with advanced breast cancer. The Cancer and Leukemia Group B.

1 reference

12 December 2020

Randomized phase III trial comparing the new potent and selective third-generation aromatase inhibitor vorozole with megestrol acetate in postmenopausal advanced breast cancer patients. North American Vorozole Study Group

1 reference

12 December 2020

Perspectives on quality of life of older patients with cancer

1 reference

12 December 2020

Pain management in older adults: prevention and treatment

1 reference

12 December 2020

Validation of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (QLQ-C30) as a measure of psychosocial function in breast cancer patients.

1 reference

12 December 2020

The prognostic value of quality-of-life scores: preliminary results of an analysis of patients with breast cancer.

1 reference

12 December 2020

A randomized trial of two dose levels of cyclophosphamide, methotrexate, and fluorouracil chemotherapy for patients with metastatic breast cancer.

1 reference

12 December 2020

1 reference

12 December 2020

Summary measures and statistics in the analysis of quality of life data: an example from an EORTC-NCIC-SAKK locally advanced breast cancer study

1 reference

12 December 2020

Doxorubicin vs epirubicin, report of a second-line randomized phase II/III study in advanced breast cancer. EORTC Breast Cancer Cooperative Group

1 reference

12 December 2020

The changeable nature of patients' fears regarding chemotherapy: implications for palliative care

1 reference

12 December 2020

General guidelines for the management of older patients with cancer

1 reference

12 December 2020

Chemotherapy of metastatic breast cancer in the elderly. The Piedmont Oncology Association experience [see comment].

1 reference

12 December 2020

QOL measurement scales for cancer patients: differentiating effects of age from effects of illness

1 reference

12 December 2020

Anastrozole is superior to tamoxifen as first-line therapy for advanced breast cancer in postmenopausal women: results of a North American multicenter randomized trial. Arimidex Study Group

1 reference

12 December 2020

Letrozole, a new oral aromatase inhibitor for advanced breast cancer: double-blind randomized trial showing a dose effect and improved efficacy and tolerability compared with megestrol acetate

1 reference

12 December 2020

Improving the quality of life during chemotherapy for advanced breast cancer. A comparison of intermittent and continuous treatment strategies.

1 reference

12 December 2020

Prognostic value of quality-of-life scores during chemotherapy for advanced breast cancer. Australian New Zealand Breast Cancer Trials Group

1 reference

12 December 2020

Assessment of quality of life in women undergoing hormonal therapy for breast cancer: validation of an endocrine symptom subscale for the FACT-B

1 reference

12 December 2020

First-line, single-agent Herceptin(trastuzumab) in metastatic breast cancer: a preliminary report

1 reference

12 December 2020

Geriatric assessment in the elderly cancer patient

1 reference

12 December 2020

Pharmacokinetics and tolerance of vinorelbine in elderly patients with metastatic breast cancer

1 reference

12 December 2020

UFT in the treatment of colorectal and breast cancer

1 reference

12 December 2020

Systematic reviews of chemotherapy and endocrine therapy in metastatic breast cancer

1 reference

12 December 2020

American Society of Clinical Oncology clinical practice guidelines for the use of chemotherapy and radiotherapy protectants

1 reference

12 December 2020

Defining clinical benefit in postmenopausal patients with breast cancer under second-line endocrine treatment: does quality of life matter?

1 reference

12 December 2020

Weekly docetaxel in the treatment of elderly patients with advanced breast cancer: a Minnie Pearl Cancer Research Network phase II trial

1 reference

12 December 2020

Breast Cancer in Older Women: Quality-of-Life Considerations.

1 reference

12 December 2020

Geriatric oncology: challenges for the new century

1 reference

12 December 2020

Improved quality of life with megestrol acetate in patients with endocrine-insensitive advanced cancer: a randomised placebo-controlled trial. Australasian Megestrol Acetate Cooperative Study Group.

1 reference

12 December 2020

Dose-finding and pharmacologic study of chronic oral idarubicin therapy in metastatic breast cancer patients

1 reference

12 December 2020

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

1 reference

12 December 2020

Multicenter phase II study of capecitabine in paclitaxel-refractory metastatic breast cancer

1 reference

12 December 2020

Clinical aspects of cancer in the elderly. Treatment decisions, treatment choices, and follow-up

1 reference

12 December 2020

Quality of life in postmenopausal patients with breast cancer after failure of tamoxifen: formestane versus megestrol acetate as second-line hormonal treatment. Swiss Group for Clinical Cancer Research (SAKK)

1 reference

12 December 2020

Combination chemotherapy compared to tamoxifen as initial therapy for stage IV breast cancer in elderly women

1 reference

12 December 2020

Systemic therapy for older women with breast cancer.

1 reference

12 December 2020

Radiotherapy for cancer patients aged 80 and older: a study of effectiveness and side effects

1 reference

12 December 2020

Patient statement of satisfaction with antiemetic treatment is related to quality of life.

1 reference

12 December 2020

Doxorubicin-based adjuvant chemotherapy in elderly breast cancer patients: the M.D. Anderson experience, with long-term follow-up

1 reference

12 December 2020

Quality of life in patients with metastatic breast cancer receiving either docetaxel or sequential methotrexate and 5-fluorouracil. A multicentre randomised phase III trial by the Scandinavian breast group.

1 reference

12 December 2020

Quality-of-life scores predict outcome in metastatic but not early breast cancer. International Breast Cancer Study Group

1 reference

12 December 2020

Strontium-89 chloride in the treatment of bone metastases from breast cancer

1 reference

12 December 2020

A phase III trial comparing anastrozole (1 and 10 milligrams), a potent and selective aromatase inhibitor, with megestrol acetate in postmenopausal women with advanced breast carcinoma. Arimidex Study Group.

1 reference

12 December 2020

Rationale for the use of mitoxantrone in the older patient: cardiac toxicity.

1 reference

12 December 2020

Prevention of chemotherapy-induced alopecia using an effective scalp cooling system

1 reference

12 December 2020

Breast cancer in older women.

1 reference

12 December 2020

Usefulness of strontium-89 for bone pain palliation in metastatic breast cancer patients

1 reference

12 December 2020

Cancer chemotherapy in the older patient: what the medical oncologist needs to know

1 reference

12 December 2020

Cost-utility analysis of second-line hormonal therapy in advanced breast cancer: a comparison of two aromatase inhibitors to megestrol acetate.

1 reference

12 December 2020

Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial

1 reference

12 December 2020

Hemopoietic reserve in the older cancer patient: clinical and economic considerations

1 reference

12 December 2020

Do patients with advanced breast cancer benefit from chemotherapy?

1 reference

12 December 2020

Dose-finding study of oral idarubicin and cyclophosphamide in first-line treatment of elderly patients with metastatic breast cancer

1 reference

12 December 2020

A comparative study of doxorubicin and epirubicin in patients with metastatic breast cancer

1 reference

12 December 2020

Anastrozole versus megestrol acetate in the treatment of postmenopausal women with advanced breast carcinoma: results of a survival update based on a combined analysis of data from two mature phase III trials. Arimidex Study Group

1 reference

12 December 2020

Effects of anti-emetic drug (tropisetron) on quality of life during chemotherapy: use of a diary-type questionnaire and application of summary measures for assessment in a randomized, multicentre study. Joint Research Group for Tropisetron Double-Bl

1 reference

12 December 2020

The geriatric cancer patient: equal benefit from equal treatment

1 reference

12 December 2020

Breast cancer in aging women. A population-based study of contrasts in stage, surgery, and survival

1 reference

12 December 2020

10.2165/00002512-200219080-00006

Identifiers

DOI

1 reference

Dimensions Publication ID

4 August 2017

1024257136

0 references

1 reference